Drug targets are biological molecules that interact with therapeutic compounds to produce a desired effect. The most common classes of targets include enzymes, proteins, and nucleic acids, each playing a distinct role in disease mechanisms and therapeutic intervention.

Enzymes
Enzymes catalyze biochemical reactions and are often dysregulated in disease. Drugs targeting enzymes typically act as inhibitors or activators, modulating activity to restore normal function. Examples include kinase inhibitors in cancer therapy and protease inhibitors in antiviral treatments.

Protein Receptors, Ion Channels, Transporters
Proteins such as G protein–coupled receptors (GPCRs), ion channels, and transporters are central to cell signaling and homeostasis. Small molecules or biologics can modulate these proteins to alter cellular responses, making them prime targets for a wide range of diseases, from neurological disorders to cardiovascular conditions.

Nucleic Acids (DNA/RNA)
Targeting nucleic acids allows for gene-level intervention. Antisense oligonucleotides, siRNAs, and CRISPR-based approaches can silence, edit, or modulate gene expression. DNA targeting chemotherapeutics preventing DNA replication aim to inhibit cancer cells replication. These strategies are especially powerful for treating genetic disorders, cancers, and viral infections.

Latest Post: